First Time Loading...

Zymeworks Inc
NYSE:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NYSE:ZYME
Watchlist
Price: 9.15 USD 1.67% Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

580.9m
+4%
Assets
Growth Rates:
1 Year
-10%
3 Years
+8%
5 Years
+138%
7 Years
+518%
10 Years
-
116.1m
-12%
Liabilities
Growth Rates:
1 Year
-25%
3 Years
-10%
5 Years
+81%
7 Years
+345%
10 Years
-
464.8m
+10%
Equity
Growth Rates:
1 Year
-6%
3 Years
+13%
5 Years
+158%
7 Years
+585%
10 Years
-

Balance Sheet Decomposition
Zymeworks Inc

580.9m
Assets
116.1m
Liabilities
580.9m
Assets
116.1m
Liabilities
Current Assets 412.9m
Cash & Short-Term Investments 374.3m
Receivables 19.5m
Other Current Assets 19.1m
Non-Current Assets 168m
Long-Term Investments 82.1m
PP&E 37.5m
Intangibles 37.3m
Other Non-Current Assets 11m
Current Liabilities 55.8m
Accounts Payable 6.2m
Accrued Liabilities 40.8m
Other Current Liabilities 8.8m
Non-Current Liabilities 60.3m
Long-Term Debt 92k
Other Non-Current Liabilities 60.2m

Balance Sheet
Zymeworks Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
47
12
16
36
42
129
242
202
401
158
Cash Equivalents
47
12
16
36
42
129
242
202
401
158
Short-Term Investments
0
4
24
52
158
171
184
51
91
217
Total Receivables
3
2
4
2
0
2
15
16
33
19
Accounts Receivables
0
2
3
0
0
2
15
16
33
19
Other Receivables
3
1
2
2
0
0
0
0
0
0
Other Current Assets
0
0
2
2
4
11
13
20
19
19
Total Current Assets
50
18
47
92
204
312
455
288
545
413
PP&E Net
1
1
7
7
7
17
18
50
48
38
PP&E Gross
1
1
7
7
7
17
18
50
48
38
Accumulated Depreciation
1
1
2
4
5
7
10
14
13
21
Intangible Assets
0
0
21
19
20
24
23
22
26
25
Goodwill
0
0
12
12
12
12
12
12
12
12
Long-Term Investments
0
4
0
0
0
0
26
1
1
82
Other Long-Term Assets
0
0
8
1
2
4
5
17
17
11
Other Assets
0
0
12
12
12
12
12
12
12
12
Total Assets
51
N/A
23
-54%
94
+307%
132
+40%
245
+85%
368
+51%
538
+46%
389
-28%
649
+67%
581
-10%
Liabilities
Accounts Payable
2
2
3
2
3
5
6
5
8
6
Accrued Liabilities
1
3
5
7
10
31
39
57
81
41
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
8
0
8
6
17
46
40
10
7
9
Total Current Liabilities
11
5
17
15
30
83
86
72
96
56
Long-Term Debt
0
0
4
0
0
0
0
0
0
0
Deferred Income Tax
0
0
5
0
0
0
1
2
2
3
Other Liabilities
0
0
0
1
34
40
42
67
58
57
Total Liabilities
11
N/A
5
-55%
26
+433%
16
-41%
64
+313%
123
+91%
129
+5%
140
+9%
156
+11%
116
-25%
Equity
Common Stock
82
84
166
223
320
450
724
741
907
1 007
Retained Earnings
44
64
98
109
145
291
471
683
559
677
Additional Paid In Capital
4
5
7
9
12
93
164
198
152
142
Other Equity
1
7
7
7
7
7
7
7
7
7
Total Equity
40
N/A
18
-54%
68
+273%
116
+71%
181
+55%
246
+36%
410
+67%
249
-39%
493
+98%
465
-6%
Total Liabilities & Equity
51
N/A
23
-54%
94
+307%
132
+40%
245
+85%
368
+51%
538
+46%
389
-28%
649
+67%
581
-10%
Shares Outstanding
Common Shares Outstanding
24
24
24
25
32
40
46
47
65
71

See Also

Summary
ZYME intrinsic value, competitors valuation, and company profile.
DCF Valuation
ZYME stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ZYME stock valuation using valuation multiples.
Wall Street Estimates
ZYME price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ZYME stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.